3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
173
Lymphoma, Non-Hodgkin
155
Leukemia, Lymphocytic, Chronic, B-Cell
154
Lymphoma, Large B-Cell, Diffuse
134
Lymphoma, Follicular
131
Lymphoma, Mantle-Cell
93
Leukemia
68
Lymphoma, B-Cell, Marginal Zone
67
Waldenstrom Macroglobulinemia
49
Burkitt Lymphoma
43
Lymphoma, B-Cell
40
Precursor Cell Lymphoblastic Leukemia-Lymphoma
36
Hodgkin Disease
36
Recurrence
24
Lymphoma, Large-Cell, Immunoblastic
24
Neoplasms
15
Myelodysplastic Syndromes
15
Lymphoma, Large-Cell, Anaplastic
15
Multiple Myeloma
13
Leukemia, Myeloid, Acute
12
Lymphoma, T-Cell, Cutaneous
9
Lymphoma, Extranodal NK-T-Cell
9
Leukemia, Hairy Cell
9
Intraocular Lymphoma
9
Hematologic Neoplasms
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Immunoblastic Lymphadenopathy
8
Sezary Syndrome
7
Mycosis Fungoides
7
Lymphoma, T-Cell
7
Interventions
Gemcitabine
43
pembrolizumab
36
Paclitaxel
36
Nivolumab
31
Docetaxel
29
Capecitabine
29
Bevacizumab
29
Oxaliplatin
28
Fluorouracil
28
Cisplatin
26
Leucovorin
24
Cyclophosphamide
23
Radiosurgery
20
Irinotecan
20
Carboplatin
20
aldesleukin
19
Cetuximab
19
Interleukin-2
16
fludarabine phosphate
15
fludarabine
15
Pemetrexed
15
Trastuzumab
14
Magnetic Resonance Spectroscopy
14
Ipilimumab
14
Fulvestrant
14
130-nm albumin-bound paclitaxel
14
Prednisone
13
Everolimus
13
Radiotherapy
12
Panitumumab
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasm Metastasis
×
Rituximab
×
Clear all
No trials found.